Gut Microbiota Alteration After Long-Term Consumption of Probiotics in the Elderly.
Gut microbiota
Probiotics
Short-chain fatty acid
Time duration
Journal
Probiotics and antimicrobial proteins
ISSN: 1867-1314
Titre abrégé: Probiotics Antimicrob Proteins
Pays: United States
ID NLM: 101484100
Informations de publication
Date de publication:
06 2019
06 2019
Historique:
pubmed:
10
3
2018
medline:
3
3
2020
entrez:
10
3
2018
Statut:
ppublish
Résumé
Gut microbiota has been proven to be of crucial importance in maintaining human health. However, the microbiota profile changes with aging, while the loss of microbiota diversity and the alterations in the optimal composition and quantity of beneficial microbes are believed to increase the risk of many diseases. Although the short-term modulatory impact of probiotics on gut microbiota has been revealed in various studies, no studies focused on longer time consumption of probiotics have been demonstrated. In this study, we found that microbial diversity in the probiotic group was similar to that in the control. We identified a panel of microbiota changes, such as Blautia (10.24 vs. 3.76%, P = 0.006), Streptococcus (7.38 vs. 1.16%, P = 0.004), and Enterococcus (0.13 vs. 0.00%, P = 0.030) were more abundant in the probiotic group. Faecalibacterium, a genus containing anti-inflammatory property, also had a higher abundance in the probiotic group in the gut. The microbiota architecture in the different probiotic dose groups was also revealed. No statistical difference was observed in regard to the short-chain fatty acid concentration between the groups. High-dose intake of probiotics resulted in lower microbial richness. The profile of inflammatory factors indicated that only the level of IL-1β was higher in the probiotic population. Taken together, our study demonstrated that the long-time intake of probiotics caused significant changes in the gut microbiota structure, including an increase in the composition of beneficial microorganisms, which might contribute to the maintenance of host health and homeostasis of microenvironment. More prospective cohorts were needed to illustrate the influences of probiotics on the gut microbiota.
Identifiants
pubmed: 29520675
doi: 10.1007/s12602-018-9403-1
pii: 10.1007/s12602-018-9403-1
doi:
Substances chimiques
Fatty Acids, Volatile
0
Interleukin-1beta
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
655-666Références
Proc Natl Acad Sci U S A. 2016 Mar 1;113(9):E1306-15
pubmed: 26884164
Nature. 2014 Sep 4;513(7516):59-64
pubmed: 25079328
ISME J. 2015 Jan;9(1):1-15
pubmed: 24936764
Clin Nutr. 2004 Oct;23(5):1069-73
pubmed: 15380897
Eur J Clin Nutr. 2002 Aug;56 Suppl 3:S65-8
pubmed: 12142967
JAMA. 2012 May 9;307(18):1959-69
pubmed: 22570464
Nature. 2006 Dec 21;444(7122):1027-31
pubmed: 17183312
Gastroenterology. 2004 Nov;127(5):1474-87
pubmed: 15521016
Nat Rev Endocrinol. 2011 Aug 09;7(11):639-46
pubmed: 21826100
Alcohol Res. 2015;37(2):223-36
pubmed: 26695747
Aliment Pharmacol Ther. 2010 Oct;32(7):872-83
pubmed: 20735782
Br J Nutr. 2002 Sep;88 Suppl 1:S67-72
pubmed: 12215182
Medicina (Kaunas). 2016;52(1):28-34
pubmed: 26987497
Ann Med. 2015;47(6):430-40
pubmed: 26340330
Anaerobe. 2012 Feb;18(1):14-8
pubmed: 22138361
JAMA Pediatr. 2013 Dec;167(12):1150-7
pubmed: 24100440
Gut. 2010 Mar;59(3):325-32
pubmed: 19091823
Sci Rep. 2015 Sep 23;5:14405
pubmed: 26396057
Nat Rev Gastroenterol Hepatol. 2012 Oct;9(10):599-608
pubmed: 22907164
Gastroenterology. 2014 May;146(6):1534-1546.e3
pubmed: 24406471
J Bacteriol. 2014 Sep;196(18):3289-302
pubmed: 25002542
Aliment Pharmacol Ther. 2013 Oct;38(7):772-83
pubmed: 23957603
Ann Oncol. 2014 Oct;25(10):1919-29
pubmed: 24618152
Br J Nutr. 2015 Feb 28;113(4):596-602
pubmed: 25630516
Aliment Pharmacol Ther. 2007 Aug 1;26(3):463-73
pubmed: 17635381
Science. 2015 Apr 3;348(6230):80-6
pubmed: 25838377
Diabetes Metab Res Rev. 2013 Feb;29(2):103-12
pubmed: 23225499
Aliment Pharmacol Ther. 2016 May;43(10):1025-34
pubmed: 26991503
Cell. 2014 Nov 6;159(4):789-99
pubmed: 25417156
Nat Med. 2016 Oct 06;22(10):1079-1089
pubmed: 27711063
Aliment Pharmacol Ther. 2004 Nov 15;20(10):1133-41
pubmed: 15569116
Aliment Pharmacol Ther. 2011 Jan;33(1):50-63
pubmed: 21083585
Am J Clin Nutr. 2007 Mar;85(3):816-23
pubmed: 17344505
Gut. 2013 May;62(5):787-96
pubmed: 23474420
Nature. 2012 Oct 4;490(7418):55-60
pubmed: 23023125
J Am Coll Nutr. 2015;34(6):459-69
pubmed: 25909149
Diabetes Metab J. 2015 Aug;39(4):291-303
pubmed: 26301190
Dig Dis Sci. 2013 Jun;58(6):1717-26
pubmed: 23306850
Science. 2015 Nov 27;350(6264):1084-9
pubmed: 26541606
Gut. 2012 Jun;61(6):829-38
pubmed: 22027478
Cell Host Microbe. 2011 Oct 20;10(4):324-35
pubmed: 22018233
J Nutr. 2014 Nov;144(11):1787-96
pubmed: 25332478
BMJ. 2013 Dec 04;347:f6471
pubmed: 24304677
Front Cell Infect Microbiol. 2017 May 05;7:167
pubmed: 28529928
Gut. 2016 Mar;65(3):415-425
pubmed: 26045134
mBio. 2015 Apr 14;6(2):
pubmed: 25873374
Aliment Pharmacol Ther. 2010 Jan 15;31(2):218-27
pubmed: 19863495
Nat Rev Gastroenterol Hepatol. 2010 Sep;7(9):503-14
pubmed: 20664519
Cell. 2016 Mar 24;165(1):111-124
pubmed: 26972052
Gut. 2004 Nov;53(11):1617-23
pubmed: 15479682
PLoS One. 2016 Mar 25;11(3):e0152126
pubmed: 27015276
Appl Environ Microbiol. 2016 Sep 16;82(19):5756-62
pubmed: 27422834
Genome Med. 2016 May 10;8(1):52
pubmed: 27159972
Cell Host Microbe. 2014 Mar 12;15(3):317-28
pubmed: 24629338
Inflamm Bowel Dis. 2015 Jul;21(7):1674-82
pubmed: 25822014
Science. 2016 Apr 29;352(6285):560-4
pubmed: 27126039
Gut Microbes. 2013 May-Jun;4(3):201-11
pubmed: 23549409
Front Microbiol. 2015 Jul 14;6:685
pubmed: 26236287